Adding Immune-based Treatments to Standard Glioblastoma Therapy

This clinical trial is testing standard therapy (surgery, radiation and temozolomide) plus immunotherapy with pembrolizumab with or without a cancer treatment vaccine for patients with newly diagnosed glioblastoma, a common and deadly type of brain tumor.

Media Type: Html Preview   0 Users liked this content.

Embed Code Snippet

To get the embed code snippet please Login.